Ms. Shin joined ProQuest in 2001 as an Associate and became a Principal in 2004. Prior to joining ProQuest, Ms. Shin served as the Director of Marketing and Business Development at Situs Corporation, a venture-backed developer of drug delivery systems. Previously, she served as a Marketing Associate at Guidant and as a Surgical Specialist at Johnson & Johnson. Prior to Johnson & Johnson, Ms. Shin worked at Boots Pharmaceuticals as a hospital sales specialist. She currently serves on the Board of Directors of Revision Optics, Inc. (RVO) and Zosano Pharma and represents ProQuest as a an observer on the Board of Directors of Immune Design Corporation and Tragara Pharmaceuticals. In addition, she has represented ProQuest as an observer on the Board of Directors of Concentric Medical and Excaliard Pharmaceuticals, among others.

Ms. Shin received a B.A. in international studies with a concentration in international trade and investment from the University of Washington and an M.B.A. from the Stanford Graduate School of Business.